Proteome Regulatory News (PRM)

13 Dec 2006 11:32

PROTEOME SCIENCES plc("the company")Total Voting Rights

In conformity with the Transparency Directive's transitional provision 6, the Company notifies the market of the following:

As at the date of this announcement, the Company's issued share capital consists of 131,465,447 ordinary shares with a nominal value of one pence each ("Ordinary Shares"), with voting rights. The Company does not hold any Ordinary Shares in Treasury.

Therefore, the total number of Ordinary Shares with voting rights is 131,465,447.

The above figure of 131,465,447 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.